Parkinson's disease, L-DOPA, and endogenous morphine: a revisit
about
Pentazocine Protects SN4741 Cells Against MPP+-Induced Cell Damage via Up-Regulation of the Canonical Wnt/β-Catenin Signaling Pathway.Neurobiological Aspects of Mindfulness in Pain Autoregulation: Unexpected Results from a Randomized-Controlled Trial and Possible Implications for Meditation Research.The effects of morphine on Parkinson's-related genes PINK1 and PARK2.The Neuroprotection of Low-Dose Morphine in Cellular and Animal Models of Parkinson's Disease Through Ameliorating Endoplasmic Reticulum (ER) Stress and Activating Autophagy.
P2860
Parkinson's disease, L-DOPA, and endogenous morphine: a revisit
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Parkinson's disease, L-DOPA, and endogenous morphine: a revisit
@ast
Parkinson's disease, L-DOPA, and endogenous morphine: a revisit
@en
Parkinson's disease, L-DOPA, and endogenous morphine: a revisit
@nl
type
label
Parkinson's disease, L-DOPA, and endogenous morphine: a revisit
@ast
Parkinson's disease, L-DOPA, and endogenous morphine: a revisit
@en
Parkinson's disease, L-DOPA, and endogenous morphine: a revisit
@nl
prefLabel
Parkinson's disease, L-DOPA, and endogenous morphine: a revisit
@ast
Parkinson's disease, L-DOPA, and endogenous morphine: a revisit
@en
Parkinson's disease, L-DOPA, and endogenous morphine: a revisit
@nl
P2093
P2860
P50
P921
P356
P1476
Parkinson's disease, L-DOPA, and endogenous morphine: a revisit
@en
P2093
Hana Kuzelova
Kirk J Mantione
Milena Králíčková
Richard M Kream
P2860
P304
P356
10.12659/MSM.883259
P407
P577
2012-08-01T00:00:00Z